2013
DOI: 10.1038/nchembio.1309
|View full text |Cite
|
Sign up to set email alerts
|

Small-molecule modulation of Wnt signaling via modulating the Axin-LRP5/6 interaction

Abstract: The Wnt/β-catenin signaling pathway has a crucial role in embryonic development, stem cell maintenance and human disease. By screening a synthetic chemical library of lycorine derivatives, we identified 4-ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine (HLY78) as an activator of the Wnt/β-catenin signaling pathway, which acts in a Wnt ligand-dependent manner. HLY78 targets the DIX domain of Axin and potentiates the Axin-LRP6 association, thus promoting LRP6 phosphorylation and Wnt signaling transd… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
82
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 79 publications
(84 citation statements)
references
References 50 publications
2
82
0
Order By: Relevance
“…5L). Previously, we identified Caprin2 as a positive regulator in Wnt/␤-catenin signaling by promoting axin-LRP5 interaction (37), and more recently, a small molecule, HLY78, was found to activate Wnt/␤-catenin signaling through modulating the interaction between axin and LRP6 (38). Here, we demonstrate that protein ubiquitination provides an alternative way to regulate axin-LRP5/6 interaction.…”
Section: Discussionmentioning
confidence: 51%
“…5L). Previously, we identified Caprin2 as a positive regulator in Wnt/␤-catenin signaling by promoting axin-LRP5 interaction (37), and more recently, a small molecule, HLY78, was found to activate Wnt/␤-catenin signaling through modulating the interaction between axin and LRP6 (38). Here, we demonstrate that protein ubiquitination provides an alternative way to regulate axin-LRP5/6 interaction.…”
Section: Discussionmentioning
confidence: 51%
“…Kim et al ., [65] proposed that without Wnt, Axin is associated with and phosphorylated by GSK3β, which is present in an activated (“open”) conformation for β-catenin binding and is poised for engagement of LRP6. In the presence of Wnt, LRP6 undergoes Fz /DVL-dependent phosphorylation and recruits active Axin from the “destruction complex” to form the signaling queue, in which GSK3β bound to Axin is inhibited by the phospho-LRP6 [7376], consequently leading to inhibition of β-catenin phosphorylation which tips the balance toward Axin dephosphorylation by PP1 phosphatase. The dephosphorylated Axin form adopts an inactivated (“closed”) conformation through intramolecular auto-inhibition and becomes incompetent for association with β-catenin or phospho-LRP6, leading to the disassembly of destruction and signaling complexes.…”
Section: Discussionmentioning
confidence: 99%
“…Dvl also mediates various β-catenin-independent, non-canonical Wnt signaling pathways, including the Rho/JNK-mediated planar cell polarity (PCP) pathway that controls actin cytoskeleton 7 . Due to its critical involvement in cancer and other diseases, the canonical Wnt pathway has been a major target for drug development 8-12 . More recently, Dvl has emerged as an attractive target for therapeutic intervention 13,14 .…”
Section: Introductionmentioning
confidence: 99%